8-KFiled Aug 12, 8:00 PM ET

Rockwell Medical Updates Corporate Presentation (Regulation FD)

$RMTI · ROCKWELL MEDICAL, INC.

Research Summary

AI-generated summary of this SEC filing

Updated

Rockwell Medical Updates Corporate Presentation (Regulation FD)

What Happened
Rockwell Medical, Inc. announced on August 13, 2026 that it made an updated corporate presentation available and furnished that presentation as Exhibit 99.1 to a Form 8‑K (Item 7.01, Regulation FD Disclosure). The company notes, per General Instruction B.2 of Form 8‑K, that the presentation is furnished—not filed—and therefore is not subject to Section 18 liability and is not incorporated by reference into registration statements except by specific reference.

Key Details

  • Filing date: August 13, 2026 (Form 8‑K, Item 7.01 Regulation FD Disclosure).
  • Exhibit provided: Exhibit 99.1 — Rockwell Medical, Inc. Corporate Presentation (dated August 13, 2026).
  • Legal treatment: Information furnished under General Instruction B.2 — not deemed “filed” for Section 18 of the Exchange Act and generally not incorporated by reference.
  • The Form 8‑K also lists inclusion of the cover page interactive data file (Inline XBRL) as Exhibit 101.

Why It Matters
This 8‑K signals Rockwell made updated investor-facing materials publicly available; investors should review Exhibit 99.1 for any slides or information the company is presenting about its business, strategy, products, or metrics. Because the presentation was furnished under Regulation FD and not “filed,” it has different legal status (limited Section 18 liability and typically not automatically incorporated into future SEC filings), but it still represents the company’s current public messaging.